Following fields are empty!
Cancer Medicine
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences, in the areas of, but not limited to, cancer biology, clinical cancer research, and cancer prevention.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Cancer Nexus
Cancer Nexus is an open-access, peer-reviewed, international journal that publishes high-quality, innovative research in the field of cancer research from clinicians, biomedical scientists, and bioinformatics engineers around the world. The journal focuses on the cutting-edge diagnosis and treatment and mechanism research in the clinical, basic and translational directions of oncology, and focuses on the cross-application of artificial intelligence in cancer clinical and basic research, aiming to establish a bridge of communication between clinical, laboratory and artificial intelligence. The journal is also interested in novel anti-tumor drugs, especially the rational design, screening and efficacy evaluation of AI-assisted anti-tumor drugs.
Cancer Nexus publishes Original Articles, Viewpoint, Case report, Review and Editorial. The journal will consider manuscripts in various fields of cancer and specific areas of interest, including but not limited to clinical trials of novel anti-cancer therapies, clinical epidemiology of cancer based on big data, AI-assisted translational cancer research, minimally invasive and non-invasive integrated diagnosis and treatment technology, cancer bioinformatics, cancer immunology and tumor vaccine development, tumor gene therapy, tumor targeted therapy, cancer omics research, mechanism research on tumor development, development and metastasis.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Cancer Reports
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Cancer Science
Cancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer. Subject categories include:
- Basic and Clinical Immunology
- Carcinogenesis
- Cell, Molecular, and Stem Cell Biology
- Clinical Research
- Drug Discovery and Delivery
- Epidemiology and Prevention
- Genetics, Genomics, and Proteomics
- Inflammation and Virology
- Pathology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Carbon Energy
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Carbon Innovation
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Carbon Neutralization
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Carbon and Hydrogen
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Cardiology Research and Practice
Cardiology Research and Practice is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of cardiology.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Cardiovascular Therapeutics
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) focuses on extensive reviews and original articles on the treatment of cardiovascular disease. The main focus of the journal is on articles in cardiovascular pharmacology and clinical pharmacology and clinical trials of new or potential cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies and pharmacoepidemiology are also encouraged.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Allergy
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Case Reports in Anesthesiology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Cardiology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Critical Care
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Dentistry
publishes case reports and case series in all areas of dentistry, including periodontal diseases, dental implants, oral pathology, as well as oral and maxillofacial surgery.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Dermatological Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Endocrinology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Gastrointestinal Medicine
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Genetics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research
Case Reports in Hematology
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion sopimus Wileyn kanssa mahdollistaa vastaaville kirjoittajille artikkeleiden julkaisemisen avoimena Wileyn full OA- ja hybridilehdissä sopimuskaudella 2025–2026. Avoimia artikkeleita voidaan julkaista rajoitettu määrä. Full OA -lehtien ja hybridilehtien artikkeleille on molemmille oma kiintiönsä:
Huom! Vuoden 2026 artikkelikiintiö Full OA -artikkeleiden osalta on loppunut.
Wileyn vuoden 2026 hybridiartikkelien kiintiö on nyt loppunut.
FinELib consortium’s agreement with Wiley enables the corresponding authors to publish their articles open access in Wiley’s Full OA and hybrid journals during the agreement term 2025–2026. The agreement includes a limited number of articles. There is a separate quota for both Full OA and hybrid journal articles:
Att! The 2026 article quota for Full OA articles has exhausted.
Wiley's 2026 hybrid articles quota has now run out.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Wileyn lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Wiley Journals
- AI guidelines for researchers: Using AI Tools in Your Research